Pfizer To Seek Nod For Malaria Drug Trials
Pfizer will soon be seeking permission from the health ministry to conduct clinical trials in India on a new drug combination for malaria.
The company plans to test the combination of its product azithromycin, an antibiotic, with chloroquine as a treatment for the disease.
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Mar 03 2003 | 12:00 AM IST